Featured Clinical Focus
AML
Biomarker-Driven Lung Cancer
Bone Marrow & SCT
BTK Inhibitors: In-Focus
CAR T-Cell Therapy
Chronic Lymphocytic Leukemia
EGFR-Positive Lung Cancer
Endometrial Cancer
Follicular Lymphoma
HCC
Lung Cancer
Mantle Cell Lymphoma
MPNs
Multiple Myeloma
Renal Cell Carcinoma
Small Cell Lung Cancer
Thyroid Cancers
AML
Biomarker-Driven Lung Cancer
Bone Marrow & SCT
BTK Inhibitors: In-Focus
CAR T-Cell Therapy
Chronic Lymphocytic Leukemia
EGFR-Positive Lung Cancer
Endometrial Cancer
Follicular Lymphoma
HCC
Lung Cancer
Mantle Cell Lymphoma
MPNs
Multiple Myeloma
Renal Cell Carcinoma
Small Cell Lung Cancer
Thyroid Cancers
Clinical Focus
View More
Brain Cancer
Breast Cancer
Gastrointestinal Cancer
Genitourinary Cancers
Gynecologic Cancers
Head & Neck Cancers
Hematology
Leukemias
Lung Cancer
Lymphomas
Melanoma
Sarcoma
Skin Cancers
Thyroid Cancers
Brain Cancer
Breast Cancer
Gastrointestinal Cancer
Genitourinary Cancers
Gynecologic Cancers
Head & Neck Cancers
Hematology
Leukemias
Lung Cancer
Lymphomas
Melanoma
Sarcoma
Skin Cancers
Thyroid Cancers
NEWS
All News
Clinical Focus
Special Reports
All News
Clinical Focus
Special Reports
CONFRENCES
Conference Coverage
Conference Listing
Conference Coverage
Conference Listing
MEDIA
All Videos
Case-Based Peer Perspectives
Expert Perspective Virtual Tumor Board
Interviews
Investigator Perspectives
Medical World News
Podcasts
Precision Medicine
All Videos
Case-Based Peer Perspectives
Expert Perspective Virtual Tumor Board
Interviews
Investigator Perspectives
Medical World News
Podcasts
Precision Medicine
PUBLICATIONS
All Publications
Evolving Paradigms
Roundtable Meetings Spotlight
Targeted Therapies in Oncology
All Publications
Evolving Paradigms
Roundtable Meetings Spotlight
Targeted Therapies in Oncology
CME/CE
RESOURCES
Case-Based Roundtable Series
Clinical Trials
Partners
Precision Medicine Perspectives
Press Releases
Sponsored Content
Treatment Resources
Case-Based Roundtable Series
Clinical Trials
Partners
Precision Medicine Perspectives
Press Releases
Sponsored Content
Treatment Resources
SUBSCRIBE
eNewsletter
eNewsletter
Search
Advertisement
Featured Clinical Focus
AML
Biomarker-Driven Lung Cancer
Bone Marrow & SCT
BTK Inhibitors: In-Focus
CAR T-Cell Therapy
Chronic Lymphocytic Leukemia
EGFR-Positive Lung Cancer
Endometrial Cancer
Follicular Lymphoma
HCC
Lung Cancer
Mantle Cell Lymphoma
MPNs
Multiple Myeloma
Renal Cell Carcinoma
Small Cell Lung Cancer
Thyroid Cancers
Clinical Focus
See All >
Brain Cancer
Breast Cancer
Gastrointestinal Cancer
Genitourinary Cancers
Gynecologic Cancers
Head & Neck Cancers
Hematology
Leukemias
Lung Cancer
Lymphomas
Melanoma
Sarcoma
Skin Cancers
Thyroid Cancers
Optimal Treatment of Chemoresistant mCRC
Optimal Treatment of Chemoresistant mCRC
EP. 1: A 60-Year-Old Male with Relapsed mCRC
March 13th 2019
EP. 2: Treatment Overview of a Patient with Relapsed mCRC
March 13th 2019
EP. 3: Determining First-Line Therapy for mCRC
March 13th 2019
EP. 4: The Challenges in Determining Second-Line Therapy for mCRC
March 13th 2019
EP. 5: The Optimal Dosing Strategy for Regorafenib in mCRC
March 13th 2019
EP. 6: Achieving a Durable Response with Regorafenib in mCRC
March 13th 2019
EP. 7: IMblaze370 Trial in MSS mCRC
March 13th 2019
EP. 8: Treatment for Chemoresistant mCRC
March 13th 2019
Advertisement
Advertisement